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Edited by Varda RotterAbstract The diphenyleneiodonium (DPI) is widely used as an
inhibitor of ﬂavoenzymes, particularly NADPH oxidase. In this
study, we investigated the eﬀect of DPI on the apoptosis of
human RPE cells. DPI treatment in ARPE-19 cells evoked a
dose- and time-dependent growth inhibition, and also induced
DNA fragmentation and protein content of the proapoptotic fac-
tor Bax. In addition, DPI signiﬁcantly induced the expression
and phosphorylation of p53, which induces proapoptotic genes
in response to DNA damage or irreparable cell cycle arrest.
ROS have been implicated as a key factor in the activation of
p53 by many chemotherapeutic drugs. Recent data on the regu-
lation of intracellular ROS by DPI are controversial. Therefore,
we analyzed whether DPI could contribute to the generation of
intracellular ROS. Although there was increase in ROS level
from cells treated for 24 h with DPI, it was not detectable at
early time points, required to induce p53 expression. And DPI-
induced p53 expression was not aﬀected by the ROS scavenger
NAC. We conclude that DPI induces the expression of p53 by
ROS-independent mechanism in ARPE-19 cells, and renders
cells sensitive to drug-induced apoptosis by induction of p53
expression.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Retinal pigment epithelial (RPE) cells are thought to con-
tribute signiﬁcantly to epiretinal membrane formation in cer-
tain diseased states such as proliferative vitreoretinopathy
(PVR) [1,2]. Although in some cases surgery can provide a
suitable means of treatment, it often proves futile. Therefore,
it is necessary to pharmacologically inhibit the proliferationAbbreviations: RPE, retinal pigmented epithelium; PVR, proliferative
vitreoretinopathy; DPI, diphenyleneiodonium; ROS, reactive oxygen
species; NAC, N-acetyl cysteine
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doi:10.1016/j.febslet.2006.12.006of RPE cells. Chemotherapeutic drugs and radiation are com-
monly used to induce cell cycle arrest and apoptosis in the
treatment of proliferating diseases such as PVR and cancer.
Among the approaches for the treatment of PVR, some
involve the use of anti-proliferative and cell cycle perturbation
agents which are DNA damaging agents that cause apoptosis
in dividing RPE cells [3,4]. Unfortunately chemotherapeutic
drugs have been toxic and lacked speciﬁcity [5–7]. We have
been studying to reduce proliferation of RPE cells as it per-
tains to both the basic drug mechanism and the potential ther-
apeutics of the pathologic conditions accompanying retinal
pigment cell proliferation [8,9].
The p53 tumor suppressor is a nuclear transcription factor,
which can induce proapoptotic or suppress antiapoptotic genes
in response to DNA damage or irreparable cell cycle arrest
[10]. Mutational inactivation of p53 has been found to be
involved in >50% of human cancers, which indicates the
importance of p53 in human carcinogenesis [11]. p53 is acti-
vated in response to stimuli such as DNA damaging agents,
UV, ionizing radiation, hypoxia, and nucleotide deprivation.
Current evidence suggests that p53 may induce cell cycle arrest
or apoptosis by a multitude of molecular pathways. The acti-
vation of p53 can mediate apoptosis by transcriptional activa-
tion of proapoptotic genes like the BH3-only proteins Noxa
and Puma [12,13], Bax [14], p53AIP1 [15], and PERP [16]
and by transcriptional repression of Bcl-2 and IAPs [17,18].
Diphenyleneiodonium (DPI) is a well-known inhibitor of
ﬂavoenzymes. It has been reported to inhibit the activity of
NADPH oxidase [19], nitric oxide synthase [20], xanthine oxi-
dase [21], and NADPH cytochrome P450 oxidoreductase [22].
Electron transport through the ﬂavin moieties of these ﬂavoen-
zymes causes reduction of DPI to its diphenyleneiodonyl rad-
ical form, followed by covalent phenylation of either the ﬂavin
or adjacent amino acid and heme groups of the proteins
[23,24]. Despite its nonspeciﬁc mode of action, DPI has fre-
quently been used to inhibit reactive oxygen species (ROS)
production mediated by ﬂavoenzymes in various types of cells
[19,25,26], where the resultant oxidants are proposed to play a
role in cell signaling [27]. In the present study, we investigated
the eﬀect of DPI on the apoptosis and the generation of intra-
cellular ROS of human RPE cells ARPE-19, and looked for
the involvement of proapoptotic factors. Our results show that
DPI renders ARPE-19 cells sensitive to drug-induced apopto-
sis by induction of p53 expression.blished by Elsevier B.V. All rights reserved.
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2.1. Reagents
DPI, hydrogen peroxide (H2O2), N-acetyl cysteine (NAC), protease
inhibitor cocktail, genistein, lactacystin, and propidium iodide were
obtained from Sigma–Aldrich Chemical Co. (St. Louis, MO, USA).
4-Hydroxy-3-methoxyacetophenone (apocynin) was purchased from
Calbiochem Co. (La Jolla, CA, USA). Anti-p53, Bcl-2, Bcl-xL, and
Bax antibodies were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Anti-human phospho-p53 (Ser-15) antibody was ob-
tained from Oncogene (Cambridge, MA, USA). 2 0-7 0-Dichlorodihy-
droﬂuorescein diacetate (H2DCF-DA) was obtained from Molecular
Probes (Eugene, OR, USA). The secondary FITC-conjugated antibod-
ies and ECL Western blotting kits were obtained from Amersham
Pharmacia Biotech (Piscataway, NJ, USA). Fetal bovine serum
(FBS), HBSS, and other tissue culture reagents were purchased from
Life Technologies (Gaithersburg, MD, USA).
2.2. Cell culture
The human RPE cell line, ARPE-19, was purchased from American
Tissue Culture Collection (Rockville, MD, USA). Cells were cultured
in a 1:1 mixture of DMEM and nutrient mixture F12 (DMEM/F12,
Gibco-BRL, NY, USA) containing 10% heat-inactivated FBS, 2 mM
L-glutamine, and antibiotics (100 U/ml of penicillin, 100 lg/ml of
streptomycin) at 37 C with 10% CO2 in air atmosphere. To maintain
reproducibility, subconﬂuent cultures were passaged according to stan-
dard trypsinization protocol, and passages 2–16 were used for all
experiments.
2.3. Growth inhibition study
For growth inhibition analysis, ARPE-19 cells were plated at 1 · 106
cells per 60-mm dishes and incubated for 24 h. Cells were cultured in
presence or absence of diﬀerent concentrations of DPI in fresh
DMEM/F12 medium supplemented with 10% FBS. After incubation,
the cells were trypsinized, washed with phosphate-buﬀered saline
(PBS) and the viable cells were scored by the trypan blue dye exclusion
method using a hemocytometer.
2.4. TUNEL assay for detection of apoptotic cells
Cytocentrifuged cells were incubated with 10 lg/ml propidium io-
dide (PI) at 37 C for 30 min. Then, cells were washed with 1% PBS/
BSA and ﬁxed in 4% paraformaldehyde for 15 min. Cells were washed
with PBS/BSA and permeabilized in 0.1% Triton-X 100 for 5 min on
ice. Next, FITC-conjugated dUTP was used to label the cells with
DNA nicking, using Apoptosis Detection System kit from Roche
Molecular Biochemicals (Mannheim, Germany) according to the man-
ufacturer’s instructions.
2.5. Western blot analysis
Equivalent amounts of total protein were loaded onto 10% SDS/
PAGE. The gels were transferred to nitrocellulose membrane using
an electroblotting apparatus (Bio-Rad, Richmond, CA, USA) and re-
acted with each antibody according to standard methods. To monitor
the degree of phosphorylated p53, cells were washed twice with ice-
cold PBS containing 1 mM Na3VO4 and incubated for 10 min on ice
with 500 ll of lysis buﬀer containing 20 mM Tris, pH7.5, 2 mM
EDTA, 2 mM EGTA, 1% v/v Triton X-100, 100 mM NaCl, 1 mM
Na3VO4, 4 mM sodium pyrophosphate, 1 mM b-glycerophosphate,
and the complete protease inhibitor mixture. Bound immunocom-
plexes were visualized on X-ray ﬁlm by ECL reagents (Amersham
Pharmacia Biotech). b-Actin was used as an internal control to moni-
tor equal protein sample loading.
2.6. Preparation and transfection of small interfering RNA (siRNA)
Twenty-one nucleotide RNA with 3 0-dTdT overhangs was synthe-
sized to interfere exclusively with p53 mRNA by Ambion (Austin,
TX) in the ‘‘ready-to-use’’ option. As a negative control, the same
nucleotides were scrambled to form a nongenomic combination (con-
trolled by basic local alignment search tool). The AA-N19 mRNA tar-
gets were p53 target sequence (5 0-GACUCCAGTGGUAAUCUAC-
3 0). Cells in exponential phase of growth were plated in 6-well plates
at 5 · 105 cells/well, grown for 24 h, and then transfected with 30 nM
of siRNA per well using siPORT Amine and Opti-MEM mediaaccording to manufacturer’s recommended protocol. The concentra-
tion of siRNA was chosen based on dose–response studies.
2.7. Measurement of intracellular ROS
Intracellular ROS was detected by monitoring changes in the ﬂuo-
rescence of the ROS-sensitive ﬂuorophore H2DCF-DA as previously
described [28]. The ﬂuorescence was measured after 10 min of incuba-
tion with H2DCF-DA using a Zeiss LSM 510 laser-scanning confocal
microscope (Go¨ttingen, Germany). Absolute ﬂuorescence intensities
were determined from the same numbers of cells in a randomly selected
area. To ensure that increased DCF ﬂuorescence was measuring
changes in oxidation and not increased uptake, ester cleavage, or ef-
ﬂux, the oxidation insensitive analog, carboxy-DCFDA (Molecular
probes, Cat. No. C-369), was used in control experiments. Measure-
ments with the oxidation insensitive probe failed to detect any diﬀer-
ences in the amount of DCF-ﬂuorescence seen in experiment with
oxidation-sensitive dye.
2.8. Statistics or reproducibility
Each experiment was performed at least three times. Statistical re-
sults were expressed as the means ± standard deviation (S.D.) of the
means obtained from each independent experiment. The results of
the experimental and control groups were tested for statistical signiﬁ-
cance by a one-tailed Student’s t test, accepting P< 0.05 as the level
of signiﬁcance.3. Results
3.1. DPI induces growth inhibition and DNA fragmentation in
human RPE cell line ARPE-19
Initial experiments were designed to determine the eﬀect of
DPI, an NADPH oxidase inhibitor, on cell growth of human
RPE cell line ARPE-19 cells. Cells were treated with dose-
dependent concentrations of DPI (0.1, 1, and 10 lM) and col-
lected at diﬀerent time point after treatment. The amount of
viable cells was measured using the trypan blue dye exclusion
method (Fig. 1A). Exposure of DPI to ARPE-19 cells resulted
in a signiﬁcant decrease of cell proliferation, without vacuola-
tion and detachment of the cells from the dish. Measurement
of DNA fragmentation using TUNEL assay was used to eval-
uate the apoptotic response of the control and cells treated
with DPI, for 24 and 48 h (Fig. 1B and C). When cells were
incubated with 10 lM DPI for 48 h, approximately 50% of
them were TUNEL-positive.
3.2. DPI stimulates upregulation and phosphorylation of p53 but
not apocynin
Next, to determine whether growth inhibition and apoptosis
induced by DPI is correlated with p53 expression, we analyzed
the amount of expressed p53 by Western blotting. Surprisingly,
DPI markedly induced the expression of p53 in a dose-depen-
dent manner (Fig. 2A). However, a catechol apocynin, which
inhibits the assembly of NADPH oxidase, did not (Fig. 2B).
And, signiﬁcantly increased level of p53 was detected at 4 h
after treatment of DPI (Fig. 2C). Phosphorylation of p53
has been shown to inﬂuence p53 activity under physiological
and stress conditions. As described previously [29], phospho-
p53 at Ser-15 physically interacts with Bcl-2 and Bcl-xL in
mitochondria and precedes cytochrome c release and mito-
chondrial membrane potential (MMP) reduction. Therefore,
we assessed levels of phospho-p53 at Ser-15 by Western blot-
ting. As expected, DPI caused phosphorylation of p53 at
Ser-15 in ARPE-19 cells (Fig. 2A). We also examined altera-
tions in protein contents of the proapoptotic factor Bax and
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Fig. 1. Eﬀect of DPI on cell growth and DNA fragmentation in human RPE cells. ARPE-19 cells were plated at 1 · 106 cells per 60-mm dishes,
incubated for 24 h, and treated with diﬀerent concentrations of DPI for 6, 12, 24, and 48 h, as indicated. (A) Measurement of viable cell number. The
viable cells were scored by hemocytometer counts of trypan blue-excluding cells. (B) TUNEL assay. TUNEL positive cells were counted under a
confocal laser-scanning microscope with 250–300 cells counted for each condition. DNA fragmentation was determined as a percentage to total cells.
Three independent experiments were performed and data shown are means ± S.D. obtained from triplicate of each experiment. (C) The photo of
DNA fragment. The merged images, resulting from the overlap of TUNEL positive (green) and PI labeling (red), were observed in the cells.
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shown to increase at 24 h after treatment of DPI. On the other
hand, the expressed level of Bcl-2 and Bcl-xL was decreased.
3.3. ROS generation from DPI-treated cells is not associated
with p53 upregulation
Although DPI, as an NADPH oxidase inhibitor, can be ex-
pected to decrease the cellular generation of ROS, recent re-
sults about this activity are controversial. Both stimulation
and inhibition of ROS generation have been reported
[25,30,31]. Therefore, we investigated whether DPI could con-
tribute to the generation of intracellular ROS in ARPE-19
cells. Cells were incubated for 24 h either in a medium alone
or in a medium that contained DPI or H2O2, and the amount
of ROS was determined quantitatively by confocal micros-
copy. As shown in Fig. 4, there was signiﬁcant increase in ﬂuo-rescent level from ARPE-19 cells treated with DPI. But, at
early time points (0.5, 1, 2, and 4 h), the generation of ROS
stimulated by DPI was not detectable. We also examined
whether DPI evokes the induction of p53 expression by regu-
lation of ROS generation. ROS scavenger NAC was utilized
to inhibit the generation of DPI-stimulated ROS. Cells were
pretreated with NAC (1 and 5 mM) for 30 min prior to DPI
stimulation. Interestingly, as shown in Fig. 5, NAC did not in-
hibit the upregulation of p53 stimulated by DPI. This result
suggests that DPI induces the upregulation of p53 by ROS-
independent mechanism in ARPE-19 cells.
3.4. p53 accumulation stimulates DPI-induced apoptosis in
ARPE-19 cells
Next, we used oligonucleotides interfering with p53 mRNA
(siRNA) for the inhibition of p53 expression. siRNA, directed
Fig. 2. Eﬀects of DPI and apocynin on upregulation and phosphor-
ylation of p53. ARPE-19 cells (2 · 106) were treated with diﬀerent
concentrations of DPI and apocynin for 24 h. Whole cell extracts were
analyzed by Western blotting, as described in Section 2. (A) Full-
length p53 and phospho-p53 (Ser-15). (B) Eﬀect of apocynin. b-Actin
was used as an internal control to monitor equal protein loading.
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Fig. 3. Eﬀect of DPI on the expression of Bcl-2, Bcl-xL, and Bax in
ARPE-19 cells. Cells were treated with diﬀerent concentrations of DPI
for 24 h. Whole cell extracts were analyzed by Western blotting using
corresponding antibodies. b-Actin was used as an internal control to
monitor equal protein loading.
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Fig. 4. Eﬀect of DPI on the generation of ROS in ARPE-19 cells. Cells
(1 · 106) were treated with 10 lMDPI or 500 lMH2O2 for 24 h. Then,
the cells were incubated with 10 lM H2DCF-DA for an additional
10 min. Cells were washed twice with PBS, and the intracellular levels
of ROS were analyzed by confocal microscope. Absolute DCF
ﬂuorescence intensities were determined from the same numbers of
cells in a randomly selected area. Values are means ± S.D. of
experiments (n P 3).
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Fig. 5. Eﬀect of NAC on the DPI-induced p53 upregulation. ARPE-19
cells were pretreated with diﬀerent concentrations of NAC (mM) for
30 min and then incubated with 10 lM DPI or 500 lM H2O2 for 24 h.
Whole cell extracts were analyzed by Western blotting using a p53
antibody. b-Actin was used as an internal control to monitor equal
protein loading.
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pletely the level of p53. The siRNA to p53 gene signiﬁcantly
inhibited p53 expression in DPI-stimulated ARPE-19 cells
(Fig. 6A). Importantly, silencing of the p53 gene signiﬁcantly
blocked the DPI-induced DNA fragmentation in ARPE-19
cells (Fig. 6B). These data suggest that upregulated p53 acts
as an important factor for apoptosis stimulated by DPI in
ARPE-19 cells.
3.5. DPI augments the drug-induced apoptosis in ARPE-19 cells
To this end, TUNEL assay was used to determine whether
DPI increases the amount of DNA fragmentation in ARPE-
19 cells stimulated with apoptosis-inducing drugs. Cells werepretreated with DPI for 12 h, and then stimulated with geni-
stein or lactacystin for an additional 24 h. When DPI-treated
cells were stimulated with genistein or lactacystin, the percent-
age of TUNEL positive cells was highly increased, compared
to cells treated with either DPI alone or with drugs (Fig. 7).
It was also demonstrated that DPI signiﬁcantly increased
drug-induced apoptotic cells, as determined by nuclear mor-
phology using Hoechst 33342 staining (data not shown). This
result means that DPI render ARPE-19 cells sensitive to drug-
induced apoptosis.4. Discussion
Apoptosis is an active cellular death process induced by nor-
mal physiological or pathological factors for elimination of un-
wanted or damaged cells [32,33]. This type of cell death has
been demonstrated in various ocular conditions [34–36]. The
hyperproliferative eye disease PVR has many parallels to can-
cer. Therefore, chemotherapeutic drugs widely used in cancer
treatments have been used to induce the apoptosis of RPE cells
in the treatment of PVR [3,5–7]. However, our understanding
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Fig. 6. Eﬀect of siRNA to p53 on DNA fragmentation in DPI-treated
ARPE-19 cells. Cells were transfected with siRNA for the silencing of
the p53 gene, as described in Section 2, and incubated in the presence
or absence of 10 lM DPI. (A) Blockage of p53 expression. After 24 h
of stimulation, the cell lysates were analyzed by Western blotting using
antibody for p53. b-Actin was used as an internal control to monitor
equal protein loading. (B) Eﬀect of p53 silencing on DNA fragmen-
tation. After 48 h of incubation, TUNEL positive cells were counted
under a confocal microscope, as described in Fig. 1. Values are
means ± S.D. of three independent cell preparations.
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Fig. 7. Eﬀects of genistein and lactacystin on DNA fragmentation in
DPI-treated ARPE-19 cells. Cells were incubated in the presence or
absence of 10 lMDPI. After 12 h of incubation, cells were treated with
10 lM genistein and 1 lM lactacystin for 24 h. TUNEL positive cells
were counted under a confocal microscope. Values are means ± S.D. of
three independent cell preparations.
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ports demonstrate that chemotherapeutic drugs [37,38], hydro-
gen peroxide [39], and radiation [40] activate the p53 pathway
for cell growth inhibition or apoptosis in RPE cells, and inhi-
bition of p53 by short hairpin RNA (shRNA) abrogates cell
cycle arrest and apoptosis in ARPE-19 cells [41].
This report demonstrates that DPI induces the expression of
p53 by ROS-independent mechanism in ARPE-19 cells, andrenders cells sensitive to drug-induced apoptosis by induction
of p53 expression. This conclusion is supported by the follow-
ing observations. Exposure of DPI resulted in a signiﬁcant de-
crease of cell growth without vacuolation and detachment of
the ARPE-19 cells. This does ﬁt with recent work in other can-
cer cells from other investigators demonstrating DPI aﬀected
selective and irreversible cell cycle inhibition of cells [42].
DPI also induced the p53 expression and the typical features
of apoptosis such as TUNEL-positive and apoptotic body for-
mation. DPI is nonspeciﬁc ﬂavin binder. Moreover, experi-
mental evidence suggests that the action of DPI and other
iodonium-containing compounds is not restricted to ﬂavoen-
zymes only [43–45].
Although DPI has frequently been used to inhibit ROS
production mediated by ﬂavoenzymes in various types of cells,
recent results of this question are still controversial [19,25,26,
30,31]. Therefore, we investigated whether DPI could contrib-
ute to the generation of intracellular ROS in ARPE-19 cells.
DPI did not induce the generation of ROS at early time points
(0.5–4 h). However, in cells incubated with DPI for 24 h, the
amount of ROS was signiﬁcantly increased. We also analyzed
whether DPI evokes the induction of p53 expression by regu-
lation of ROS generation. The ROS scavenger NAC was uti-
lized to inhibit the generation of DPI-stimulated ROS.
Although NAC inhibited p53 accumulation induced by H2O2
generating ROS, it did not inhibit the upregulation of p53
stimulated by DPI. Our ﬁndings suggest that DPI induces
the upregulation of p53 by ROS-independent mechanism in
ARPE-19 cells. And these accumulated evidences provide a
functional connection between the expression of p53 by
ROS-independent mechanism and the increase of intracellular
ROS in DPI-treated ARPE-19 cells. Indeed, ROS have been
implicated as second messengers at multiple levels in the p53
signaling. First, the generation of ROS is a key factor in the
activation of p53 by many chemotherapeutic drugs. Second,
p53 activation itself results in the generation of ROS, suggest-
ing that an important consequence of p53 activation is a
further increase in the level of oxidative stress [46,47]. How-
ever, exactly how p53 activation leads to elevations in ROS
is unclear.
In conclusion, the results presented in this report demon-
strate that DPI induces growth inhibition and apoptosis of
human RPE cells, which may be associated with the induction
of p53 expression. The results also show that DPI induces the
expression of p53 by ROS-independent mechanism in ARPE-
19 cells. The p53 expression could have an important role in
the development of therapeutic strategies attempting to stimu-
late apoptosis in the treatment of PVR. And further studies are
required to elucidate whether DPI regulates the p53 expression
by ROS-independent or -dependent mechanism in other cell
types.Acknowledgment: This work was supported by the grant (KRF-2004-
005-E00007) of Korea Research Foundation.Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.2006.
12.006.
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